Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trypanosoma cruzi | Peptide deformylase 2, putative | 0.0087 | 0 | 0.5 |
Mycobacterium leprae | PROBABLE POLYPEPTIDE DEFORMYLASE DEF (PDF) (FORMYLMETHIONINE DEFORMYLASE) | 0.0229 | 1 | 0.5 |
Trypanosoma cruzi | polypeptide deformylase-like protein, putative | 0.0087 | 0 | 0.5 |
Leishmania major | polypeptide deformylase-like protein, putative | 0.0087 | 0 | 0.5 |
Trypanosoma brucei | Peptide deformylase 2 | 0.0087 | 0 | 0.5 |
Trypanosoma cruzi | polypeptide deformylase-like protein, putative | 0.0087 | 0 | 0.5 |
Plasmodium falciparum | peptide deformylase | 0.0229 | 1 | 0.5 |
Treponema pallidum | polypeptide deformylase (def) | 0.0229 | 1 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | peptide deformylase | 0.0229 | 1 | 0.5 |
Plasmodium vivax | peptide deformylase, putative | 0.0229 | 1 | 0.5 |
Trypanosoma brucei | Polypeptide deformylase 1 | 0.0087 | 0 | 0.5 |
Toxoplasma gondii | hypothetical protein | 0.0229 | 1 | 0.5 |
Mycobacterium ulcerans | peptide deformylase | 0.0229 | 1 | 0.5 |
Trypanosoma cruzi | Peptide deformylase 2, putative | 0.0087 | 0 | 0.5 |
Mycobacterium tuberculosis | Probable polypeptide deformylase Def (PDF) (formylmethionine deformylase) | 0.0229 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 135 % | Cytotoxicity against mouse RAW264.7 cells assessed as cell viability at 10 uM by MTT assay | ChEMBL. | 19233646 |
Inhibition (binding) | = 11 % | Inhibition of COX2-mediated PGE2 production in LPS-stimulated mouse RAW264.7 cells at 10 uM by enzyme immunoassay | ChEMBL. | 19233646 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.